FeesSafety
Pluang+

Class action lawsuit filed against Babcock & Wilcox for securities losses between Nov 2025 and Mar 2026

Market News
29 Oct 2026, 17:00 WIB
PRNewsWire
View Source
Bearish
Class action lawsuit filed against Babcock & Wilcox for securities losses between Nov 2025 and Mar 2026

A class action lawsuit has been initiated against Babcock & Wilcox Enterprises, Inc. for investors who bought securities between November 5, 2025, and March 11, 2026. The law firm Pomerantz LLP, known for handling securities class actions, is representing affected investors. This lawsuit alleges securities fraud or corporate misconduct that may have caused investor losses. Investors who believe they were impacted are encouraged to contact the law firm for more information on joining the case.

Babcock & Wilcox Enterprises, Inc. is the subject of a recent class action lawsuit. For readers following Industrials-sector stocks, here is Pluang's market snapshot as of Oct 29, 2026 20:41 WIB: out of 135 priced US Industrials stocks, 92 rose and 43 fell. Notable movers include CAT (Caterpillar Inc) at USD 647.30 with a 1-day change of -9.26% and Pluang order activity of 45% Sell / 55% Buy, FTAI (FTAI Aviation Ltd) at USD 182.44 with a 1-day change of +9.15%, and TT (Trane Technologies plc) at USD 415.32 with a 1-day change of -7.39%.

More News

NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

Naples Comprehensive Health (NCH) has completed the first tricuspid valve repair in the US using the PASCAL Precision system following FDA approval. This minimally invasive catheter-based procedure offers a new treatment option for patients with seve...

Market News
Bullish
1 hour ago
Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore Holdings will present Phase 1/2 clinical trial data for brenetafusp alone and combined with KIMMTRAK in treating metastatic uveal melanoma at the 2026 Society for Immunotherapy of Cancer meeting. This trial evaluates safety and efficacy in...

Company Fundamentals
Bullish
1 hour ago
Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC have extended their partnership to include youth coach training, an annual Sports for All Summit, and sensory inclusion programs aimed at supporting neurodivergent children, especially those with ADHD, in...

Others
Bullish
2 hours ago
Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks announced that its CEO Adi Sfadia and CFO Gil Benyamini will attend the Deutsche Bank Global Space and Defense Tech Summit on November 18, 2026, in New York City. The event will feature one-on-one and group meetings, providin...

Market News
Neutral
2 hours ago
Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex Inc. has acquired Wind2, a UK-based renewable energy developer with about 350 MW of advanced wind projects across Scotland, England, and Wales. This acquisition strengthens Boralex's presence and capabilities in the UK, aligning with its stra...

Company Fundamentals
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App